Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
275 studies found for:    "Expanded Access" [STUDY-TYPES]
Show Display Options
RSS Create an RSS feed from your search for:
"Expanded Access" [STUDY-TYPES]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Available An Extended Access Program for Perampanel
Condition: Partial Onset Seizures
Intervention: Drug: Perampanel
2 Available Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Condition: Chronic Myeloid Leukemia
Intervention: Drug: bosutinib
3 Available Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
Condition: Lambert-Eaton Myasthenic Syndrome
Intervention: Drug: 3,4 DAP
4 No longer available B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Allogeneic Pancreatic Islet Cells;   Drug: Sirolimus;   Biological: Basiliximab;   Drug: Tacrolimus;   Drug: Antibacterial, Antifungal, and Antiviral Prophylaxis;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Clotrimazole;   Drug: Valganciclovir;   Drug: Heparin;   Drug: Enoxaparin;   Drug: Pentoxifylline;   Drug: Aspirin
5 Available Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease
Conditions: Cholestasis;   Short Bowel Syndrome
Intervention: Drug: Omegaven
6 Available 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)
Conditions: Lambert-Eaton Myasthenic Syndrome (LEMS);   Congenital Myasthenia (CM)
Intervention: Drug: 3,4-diaminopyridine
7 No longer available Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Ritonavir
8 Available Prevention of Transmission of Sexually Transmitted Diseases in the Youth Through Effective Intervention,
Condition: HIV
Intervention: Behavioral: Lifestyle Counseling
9 No longer available Fosamprenavir Expanded Access
Condition: HIV Infection
Interventions: Drug: fosamprenavir;   Drug: Telzir®
10 No longer available Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy
Condition: Metastatic Renal Cell Cancer
Intervention: Drug: Everolimus
11 Approved for marketing Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection
Conditions: Cystic Fibrosis;   Pseudomonas Aeruginosa Airway Infection
Intervention: Drug: Aztreonam Lysine for Inhalation
12 Available Expanded Access Study of Amifampridine Phosphate in LEMS, Congenital Myasthenic Syndrome, or Downbeat Nystagmus Patients
Conditions: Lambert-Eaton Myasthenic Syndrome;   Congenital Myasthenic Syndrome;   Downbeat Nystagmus
Intervention: Drug: Amifampridine Phosphate
13 Available TX2® Low Profile TAA Endovascular Graft
Conditions: Aortic Aneurysm;   Penetrating Ulcer;   Vascular Disease
Intervention: Device: Zenith® TX2® Low Profile TAA Endovascular Graft (Thoracic Aortic Aneurysm)
14 Approved for marketing Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) System
Condition: Congestive Heart Failure (CHF)
Intervention: Device: Ovatio CRT
15 Unknown  Weight-bearing Measuring Device to Determine Normative Percentage Body-Weight/Weight-Bearing Values and Weight-bearing Gait Characteristics
Conditions: Percentage Body-Weight;   Weight-Bearing Values;   Weight-bearing Gait Characteristics
Intervention: Device: SmartStep insole
16 Available Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma
Conditions: Pheochromocytoma;   Paraganglioma
Intervention: Drug: 131 I-Metaiodobenzylguanidine (131 I-MIBG)
17 Available 68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors
Conditions: Carcinoid Tumors;   Islet Cell (Pancreatic NET);   Other Neuroendocrine Tumors
Intervention: Drug: 68Ga-DOTA TATE
18 No longer available Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute GVHD
Condition: Graft-Versus-Host Disease
Intervention: Drug: Prochymal®
19 No longer available Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
Condition: Lambert Eaton Myasthenic Syndrome (LEMS)
Intervention: Drug: 3,4-diaminopyridine
20 Unknown  HIV-discordant Couple Intrauterine Insemination
Conditions: Infertility;   HIV Infections
Interventions: Other: Sperm washing and testing for HIV contamination;   Procedure: Intrauterine Insemination

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years